Folgen
Praveen Yerramothu
Praveen Yerramothu
Research Scientist, University of Virginia
Bestätigte E-Mail-Adresse bei virginia.edu
Titel
Zitiert von
Zitiert von
Jahr
Inflammasomes, the eye and anti-inflammasome therapy
P Yerramothu, AK Vijay, MDP Willcox
Eye 32 (3), 491-505, 2018
1322018
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration
S Fukuda, A Varshney, BJ Fowler, S Wang, S Narendran, K Ambati, ...
Proceedings of the National Academy of Sciences 118 (6), e2022751118, 2021
432021
A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling
D Banerjee, K Langberg, S Abbas, E Odermatt, P Yerramothu, M Volaric, ...
Nature Communications 12 (1), 6207, 2021
392021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs
S Wang, S Narendran, S Hirahara, A Varshney, F Pereira, I Apicella, ...
Science immunology 6 (66), eabi4493, 2021
312021
Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity
S Fukuda, S Narendran, A Varshney, Y Nagasaka, S Wang, K Ambati, ...
Science Advances 7 (40), eabj3658, 2021
252021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration
S Narendran, F Pereira, P Yerramothu, I Apicella, S Wang, K Ambati, ...
Signal Transduction and Targeted Therapy 6 (1), 149, 2021
192021
New therapies of neovascular AMD—beyond anti-VEGFs
P Yerramothu
Vision 2 (3), 31, 2018
192018
A clinical metabolite of azidothymidine inhibits experimental choroidal neovascularization and retinal pigmented epithelium degeneration
S Narendran, F Pereira, P Yerramothu, I Apicella, S Wang, A Varshney, ...
Investigative ophthalmology & visual science 61 (10), 4-4, 2020
122020
Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization
S Wang, Y Nagasaka, D Argyle, A Nagasaka, P Yerramothu, BD Gelfand, ...
Signal Transduction and Targeted Therapy 8 (1), 72, 2023
52023
The learning curve of murine subretinal injection among clinically trained ophthalmic surgeons
P Huang, S Narendran, F Pereira, S Fukuda, Y Nagasaka, I Apicella, ...
Translational Vision Science & Technology 11 (3), 13-13, 2022
52022
Subretinal injection in mice to study retinal physiology and disease
P Huang, S Narendran, F Pereira, S Fukuda, Y Nagasaka, I Apicella, ...
Nature Protocols 17 (6), 1468-1485, 2022
32022
Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal Detachment
P Huang, CC Thomas, K Ambati, R Dholkawala, A Nagasaka, ...
Investigative Ophthalmology & Visual Science 64 (5), 3-3, 2023
22023
Association between haloperidol use and risk of rheumatoid arthritis
VL Ambati, TH Cummings, P Yerramothu, J Nguyen, SS Sutton, ...
medRxiv, 2023
12023
Reduction of human Alzheimer’s disease risk and reversal of mouse model cognitive deficit with nucleoside analog use
J Magagnoli, P Yerramothu, K Ambati, T Cummings, J Nguyen, ...
medRxiv, 2023
12023
Kamuvudine-9 protects retinal structure and function in a novel model of experimental rhegmatogenous retinal detachment
CC Thomas, P Huang, K Ambati, S Narendran, F Pereira, I Apicella, X Cai, ...
Investigative Ophthalmology & Visual Science 64 (8), 4888-4888, 2023
2023
Haloperidol inhibits inflammasome activation via LAMTOR1 and reduces the risk of arthritides
V Ambati, P Yerramothu, R Konduri, J Nguyen, BD Gelfand, BC Werner, ...
medRxiv, 2023.12. 06.23299609, 2023
2023
Macrophage polarization in bacterial keratitis: A link with NLRP3 inflammasome
P Yerramothu, AK Vijay, M Willcox
Investigative Ophthalmology & Visual Science 59 (9), 3319-3319, 2018
2018
Role of the NLRP3 Inflammasome in bacterial keratitis
P Yerramothu
UNSW Sydney, 2018
2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–18